biotech · Relapsed/Refractory Large B Cell Lymphoma · Relapsed/Refractory Multiple Myeloma · ALLO
Allogene Therapeutics
Allogene Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
South San Francisco, USA HQ
2017 Founded
208 Employees
Public company Type
ALLO · NYSE Ticker
Company details
- Status
- Public
- HQ
- South San Francisco, USA
- Founded
- 2017
- Employees
- 208
- Programs
- 8
- Drugs
- 2
- Patents
- 16
Allogene Therapeutics clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to Allogene Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Allogene Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Allogene Therapeutics.